Oxford Pharmascience Group PLC Subdivision of Capital (3192Y)
December 04 2017 - 9:14AM
UK Regulatory
TIDMOXP
RNS Number : 3192Y
Oxford Pharmascience Group PLC
04 December 2017
Oxford Pharmascience Group plc
("Oxford Pharmascience" or the "Company")
Subdivision of Capital
Oxford Pharmascience Group plc (AIM: OXP) announces that, as
contemplated in the Circular to Shareholders issued by the Company
on 10 November 2017 and pursuant to the resolutions passed at a
general meeting of shareholders on 27 November 2017, the Company
has completed a subdivision of its capital whereby each Existing
Share of GBP0.001 has been subdivided and reclassified into 1 New
Share of GBP0.00001 and 1 Participating Deferred Share of
GBP0.00099 (the "Subdivision").
Following the Subdivision the issued share capital of the
Company consists of 1,205,661,619 New Shares of GBP0.00001 each and
1,205,661,619 Participating Deferred Shares of GBP0.00099 each.
Following the Subdivision, each Existing Shareholder's holding
shall remain unchanged therefore no new share certificates will be
issued. The total voting rights in the Company also remains
unchanged, with 1,205,661,619 New Shares in issue. This figure may
be used by Shareholders as the denominator for the calculations by
which they will determine whether they are required to notify their
interest in, or a change to their interest in, the Company under
the Financial Conduct Authority's Disclosure and Transparency
Rules.
The Capital Reduction remains subject to the Court's approval
and a further announcement in relation to this and the Demerger
will be made in due course.
Unless otherwise indicated, capitalised terms in this
announcement have the meaning given to them in the definitions
appearing in the circular issued by the Company on 10 November
2017.
For further information please contact:
Oxford Pharmascience Group
Plc
----------------------------- -----------------
Chris Hill, Chief Financial
Officer +44 20 7554 5875
----------------------------- -----------------
N+1 Singer (Nominated
Adviser & Broker)
----------------------------- -----------------
Aubrey Powell/Jen Boorer +44 20 7496 3000
----------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCOKQDDQBDDDBK
(END) Dow Jones Newswires
December 04, 2017 09:14 ET (14:14 GMT)
Alba (LSE:ABA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Alba (LSE:ABA)
Historical Stock Chart
From Jan 2024 to Jan 2025